$50 Billion in Sales Make Ozempic and Wegovy Prices Tougher to Justify
Ozempic and Wegovy are making so much money for Novo Nordisk A/S that their cumulative sales will soon surpass the ...
Lisa Jarvis: The best treatment for COVID is still too hard to get
We’re still asking people with COVID to jump through far too many hoops to get their hands on Pfizer Inc.’s Paxlovid.” ...
Eagle-Tribune5 天Opinion
The best treatment for COVID is still too hard to get
We’re still asking people with COVID to jump through far too many hoops to get their hands on Pfizer Inc.’s Paxlovid.
Walla Walla Union Bulletin5 天Opinion
Commentary: The best treatment for COVID is still too hard to get
We’re still asking people with COVID to jump through far too many hoops to get their hands on Pfizer Inc.’s Paxlovid.
Ozempic and Wegovy Sales Will Soon Pay for $68 Billion of Novo R&D
Ozempic and Wegovy are making so much money for Novo Nordisk A/S that their cumulative sales will soon surpass the ...